Novofem (Estradiol | Norethisterone Acetate, Estradiol)

The estradiol component provides estrogenic activity, while norethisterone acetate acts as a progestogen. Together they suppress the mid‑cycle surge of luteinising hormone (LH) and follicle‑stimulating hormone (FSH), preventing ovulation. They also thicken cervical mucus and alter the endometrial lining, reducing the chance of fertilisation and implantation.

The specific dosing regimen for Novofem is determined by the prescribing healthcare professional based on individual patient needs and local guidelines. Patients should follow the prescriber’s instructions and the product’s package insert for the correct schedule.

Novofem is contraindicated during pregnancy; it should be discontinued if pregnancy is confirmed. Safety during breastfeeding has not been established, and the decision to use hormonal contraception while nursing should be made by a healthcare provider after weighing potential risks and benefits.

To request Novofem, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After the enquiry, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details and any required import documentation.

Novofem contains estradiol rather than ethinyl‑estradiol, which may offer a different hormonal profile and side‑effect spectrum compared with many other combined pills. Its efficacy in preventing pregnancy is comparable, but individual tolerability can vary, making it a suitable alternative for patients who prefer estradiol‑based formulations.

Novofem tablets should be stored at ambient temperature, below 25 °C. Keep them in the original packaging, protect from moisture and light, and store out of reach of children.

Novofem is taken orally, usually once daily at the same time each day, as directed by the prescriber. The tablets are swallowed whole with water and should not be chewed or broken.

Serious risks include venous thromboembolism, stroke, myocardial infarction, severe hypertension, liver tumors and severe allergic reactions. Patients should seek immediate medical attention if they experience symptoms such as sudden chest pain, shortness of breath, severe headache, visual changes, or unusual swelling.

Novofem is contraindicated in women with a history of thromboembolic disorders, uncontrolled hypertension, active liver disease, known or suspected breast cancer, or those who are pregnant. It should also be avoided by women over 35 who smoke and by individuals with known hypersensitivity to any component of the product.